Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China flag China · Delayed Price · Currency is CNY
16.53
-0.12 (-0.72%)
At close: Feb 6, 2026

SHA:600161 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,8982,6864,5553,7134,3301,748
Cash & Short-Term Investments
1,8982,6864,5553,7134,3301,748
Cash Growth
-60.51%-41.04%22.68%-14.25%147.68%23.69%
Accounts Receivable
2,2971,12194.131,1731,027695.59
Other Receivables
8.313.4539.0828.3622.2716.93
Receivables
2,3051,134133.211,2011,050712.52
Inventory
4,0353,8692,8442,3322,1442,172
Other Current Assets
34.0933.436.5324.8722.2723.64
Total Current Assets
8,2717,7227,5697,2717,5464,656
Property, Plant & Equipment
5,9215,8484,8864,0552,6311,997
Long-Term Investments
143.2143.2146.06146.06146.06121.59
Goodwill
572.15572.15173.92173.92127.93115.01
Other Intangible Assets
881.88917.05686.88441.63370.99252.44
Long-Term Deferred Tax Assets
61.8441.7746.7460.6367.0163.11
Long-Term Deferred Charges
596.81507.82470.26552.69362.46174.08
Other Long-Term Assets
103.03117.66208.66228.88326.85161.34
Total Assets
16,55115,87014,18812,92911,5787,541
Accounts Payable
95.8881.45179.169.3973.745.86
Accrued Expenses
283.89170.46168.69163.21150.02146.85
Short-Term Debt
145.56----200.13
Current Portion of Long-Term Debt
---112.99108.15126.25
Current Portion of Leases
15.118.9617.9510.8216.51-
Current Income Taxes Payable
118.84148.2161.8573.7944.8636.63
Current Unearned Revenue
191.24213.19357.26292.72215.31200.66
Other Current Liabilities
524.74498.07494.78434.44201.03182.98
Total Current Liabilities
1,3751,1201,2801,157809.58939.36
Long-Term Debt
---253.75366.25474.59
Long-Term Leases
70.3544.8624.4225.6218.01-
Long-Term Unearned Revenue
103.48107.4499.56101.992.6980.83
Pension & Post-Retirement Benefits
-----0.06
Long-Term Deferred Tax Liabilities
53.5262.4428.8530.8720.1411.15
Other Long-Term Liabilities
1.241.241.244.14.14.1
Total Liabilities
1,6041,3361,4341,5741,3111,510
Common Stock
1,9771,9771,6481,6481,3731,254
Additional Paid-In Capital
2,4632,4632,7932,7933,067274.62
Retained Earnings
7,0236,6985,3824,3553,6122,989
Comprehensive Income & Other
-0.1-0.1-0.1-0.1-0.1-0.1
Total Common Equity
11,46311,1399,8238,7958,0524,518
Minority Interest
3,4843,3942,9322,5602,2151,513
Shareholders' Equity
14,94714,53312,75411,35610,2676,031
Total Liabilities & Equity
16,55115,87014,18812,92911,5787,541
Total Debt
231.0153.8242.37403.17508.92800.97
Net Cash (Debt)
1,6672,6324,5133,3103,821947.15
Net Cash Growth
-65.03%-41.68%36.34%-13.38%303.40%-6.48%
Net Cash Per Share
0.841.332.281.661.970.52
Filing Date Shares Outstanding
1,9771,9771,9771,9771,9771,806
Total Common Shares Outstanding
1,9771,9771,9771,9771,9771,806
Working Capital
6,8966,6026,2906,1136,7363,717
Book Value Per Share
5.805.634.974.454.072.50
Tangible Book Value
10,0099,6508,9628,1807,5534,150
Tangible Book Value Per Share
5.064.884.534.143.822.30
Buildings
-2,7112,2411,957963.02949.32
Machinery
-2,7602,2181,9961,2581,177
Construction In Progress
-2,4782,0441,5321,6231,030
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.